BioSpace News Archive

BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, reported financial results, and provided a business update for the first quarter ended March 31, 2022.

Johnson & Johnson announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of the future, listed New Consumer Health Company.

Amryt Announces New Patent for Mycapssa® .

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration has approved OLUMIANT® for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation with a recommended dose of 4-mg once daily for 14 days or until hospital discharge, whichever comes first.

Immunocore Reports today announced its financial results for the first quarter ended March 31, 2022 and provided a business update.

SaNOtize Research and Development announced results from a retrospective clinical study assessing the efficacy of nitric oxide releasing nasal spray in preventing COVID-19 infection after high-risk exposure.

Atmofizer Technologies Inc. (the “Company” or “Atmofizer”) (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) is pleased to announce the Company’s test results of its airborne nanoparticle agglomeration engine.

Babson Diagnostics and BD announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing.

Taysha Gene Therapies, Inc. today announced that it will report its financial results for the first quarter ended March 31, 2022, and host a corporate update conference call and webcast on Monday, May 16, 2022, at 8:00 AM Eastern Time.

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, reported its financial and operating results for the three months ended March 31, 2022.